Neuromyelitis Optica Spectrum Disorder Podcast Series

1.00 CME
1.00 CME with ABO CC
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Neuromyelitis Optica Spectrum Disorder Podcast Series


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Activity Description

Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease of the central nervous system, mainly manifesting through recurrent attacks of optic neuritis and longitudinally extensive transverse myelitis. Early stages are frequently misdiagnosed as multiple sclerosis. Application of newer diagnostic criteria for NMOSD may help physicians diagnose patients earlier and with greater accuracy. Such diagnostic criteria may also help identify individuals who might otherwise have been misdiagnosed with idiopathic transverse myelitis, idiopathic optic neuritis, or atypical multiple sclerosis. Although NMOSD treatment options have traditionally been limited, several biologics have been FDA-approved in the past few years. In this podcast series, expert clinicians discuss updates in the diagnosis and treatment of NMOSD, as well as a challenging case.

Target Audience

The intended audience for this activity is ophthalmologists, neuro-ophthalmologists, neurologists, optometrists and other health care professionals involved in the management of patients with neuromyelitis optica spectrum disorder.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Outline evidence-based criteria and best practices that can improve the differential diagnosis of neuromyelitis optica spectrum disorder (NMOSD).
  • Differentiate the mechanisms of action of current NMOSD treatments to better understand how they treat the disorder and may reduce recurrent attacks.
  • Evaluate the efficacy and safety of conventional and new therapies when determining the most appropriate treatment for patients with NMOSD.

Activity Chair

Prem S. Subramanian, MD, PhD
Professor of Ophthalmology, Neurology, and Neurosurgery
University of Colorado School of Medicine
Vice Chair for Academic Affairs
Division Head, Neuro-Ophthalmology
UCHealth Sue Anschutz-Rodgers Eye Center
Aurora, CO


Patricia K. Coyle, MD, FAAN, FANA
Professor and Vice Chair (Clinical Affairs)
Department of Neurology
Director, Multiple Sclerosis Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, NY

Andrew G. Lee, MD
Chairman of Ophthalmology
Blanton Eye Institute
Houston Methodist Hospital
Clinical Professor of Ophthalmology
University of Texas Medical Branch MD Anderson Cancer Center
Adjunct Professor of Ophthalmology
Baylor College of Medicine
Houston, TX
Professor of Ophthalmology, Neurology, and Neurosurgery
Weill Cornell Medical College
New York, NY
Clinical Professor of Ophthalmology
University of Buffalo, SUNY
Buffalo, NY
Adjunct Professor of Ophthalmology
University of Iowa
Iowa City, IA

Michael S. Lee, MD
Professor, Departments of Ophthalmology and Visual Neurosciences, Neurosurgery, and Neurology
Mackall-Scheie Research Chair
Director, Ophthalmology Residency Program
Director, Neuro-Ophthalmology Service
University of Minnesota
Minneapolis, MN

Dean M. Wingerchuk, MD, MSc, FRCP(C)
Professor of Neurology
Chair, Department of Neurology
Mayo Clinic
Phoenix/Scottsdale, AZ


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit.

Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn credits equivalent to the amount of CME credits claimed for the activity.

This enduring material is approved for 1 year from the date of original release, May 31, 2021, to May 30, 2022.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.  

Activity Chair and Faculty report the following relationship(s)

Patricia K. Coyle, MD, FAAN, FANA
Consulting Fee: Accordant, Biogen, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Novartis, Sanofi Genzyme, Viela Bio
Speakers Bureau: Biogen, Janssen
Contracted Research: Actelion, Alkermes, Corrona, Genentech, MedDay, NINDS, Novartis

Andrew G. Lee, MD
No relevant financial relationships to disclose.

Michael S. Lee, MD
No relevant financial relationships to disclose.

Prem S. Subramanian, MD, PhD
Contracted Research: Horizon

Dean M. Wingerchuk, MD, MSc, FRCP(C)
Consulting Fee: Arcus Medica, Biogen, Celgene, Genentech, MedImmune, Novartis, Reistone, TG Therapeutics, Third Rock Ventures
Contracted Research: Alexion, Terumo BCT

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at